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Abstract
Introduction Manifestations of sepsis are sensitive but are
poorly specific of infection. Our aim was to assess the value of
daily measurements of C-reactive protein (CRP), temperature
and white cell count (WCC) in the early identification of
intensive care unit (ICU)-acquired infections.
Methods We undertook a prospective observational cohort
study (14 month). All patients admitted for ≥72 hours (n = 181)
were divided into an infected (n = 35) and a noninfected group
(n = 28). Infected patients had a documented ICU-acquired
infection and were not receiving antibiotics for at least 5 days
before diagnosis. Noninfected patients never received
antibiotics and were discharged alive. The progression of CRP,
temperature and WCC from day -5 to day 0 (day of infection
diagnosis or of ICU discharge) was analyzed. Patients were
divided into four patterns of CRP course according to a cutoff
value for infection diagnosis of 8.7 mg/dl: pattern A, day 0 CRP
>8.7 mg/dl and, in the previous days, at least once below the
cutoff; pattern B, CRP always >8.7 mg/dl; pattern C, day 0 CRP
≤8.7 mg/dl and, in the previous days, at least once above the
cutoff; and pattern D, CRP always ≤8.7 mg/dl.
Results CRP and the temperature time-course showed a
significant increase in infected patients, whereas in noninfected
it remained almost unchanged (P  < 0.001 and P  < 0.001,
respectively). The area under the curve for the maximum daily
CRP variation in infection prediction was 0.86 (95% confidence
interval: 0.752–0.933). A maximum daily CRP variation >4.1
mg/dl was a good marker of infection prediction (sensitivity
92.1%, specificity 71.4%), and in combination with a CRP
concentration >8.7 mg/dl the discriminative power increased
even further (sensitivity 92.1%, specificity 82.1%). Infection was
diagnosed in 92% and 90% of patients with patterns A and B,
respectively, and in only two patients with patterns C and D (P
< 0.001).
Conclusion Daily CRP monitoring and the recognition of the
CRP pattern could be useful in the prediction of ICU-acquired
infections. Patients presenting maximum daily CRP variation
>4.1 mg/dl plus a CRP level >8.7 mg/dl had an 88% risk of
infection.
Introduction
Nosocomial infections are an increasingly common cause of
morbidity and mortality [1], particularly among critically ill
patients [2,3]. In intensive care units (ICUs), clinicians are
repeatedly faced with two challenges: whether a patient is
infected and whether antibiotic therapy is doing any good.
Sepsis is defined as the host response to an infection and is
characterized by a number of signs such as fever, tachycardia,
tachypnea and leukocytosis [4,5]. These signs are very sensi-
tive but are poorly specific of infection, can occur in a variety
of noninfectious conditions [6,7] and can be influenced by
commonly used drugs [8]. Untreated bacterial infections may
cause serious complications, but treating noninfectious
causes with antimicrobials is ineffective and also increases
costs, toxicity and the risk of development of bacterial resist-
ance. A better knowledge of the inflammatory cascade has
given new insights and provided several mediators that [9], in
conjunction with the clinical manifestations of sepsis, can be
APACHE II = Acute Physiology and Chronic Health Evaluation II; AUC = area under the curve; CRP = C-reactive protein; ICU = intensive care unit; 
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useful as markers of infection. C-reactive protein (CRP) is one
such mediator and is probably the most widely used marker
[10-12].
CRP is an acute-phase protein, stably conserved throughout
vertebrate evolution, suggesting a central role in immunologi-
cal response [13]. It is synthesized in the liver mainly in
response to IL-6 and binds to polysaccharides of pathogens
promoting phagocytosis [14]. Several studies have shown
that CRP could be useful in infection diagnosis [10] as well as
in monitoring the response to antibiotic therapy [12,15].
As CRP measurement is a rapid, reproducible and inexpensive
test, the aim of our study was to evaluate whether daily CRP
monitoring as well as the assessment of CRP patterns of pro-
gression could be useful in the early identification of patients
with ICU-acquired infections, in comparison with commonly
used markers such as temperature and white cell count
(WCC).
Materials and methods
The study was conducted in an eight-bed medico-surgical ICU
of the Garcia de Orta Hospital, Almada, Portugal, which
admits patients from all hospital departments as well as from
other hospitals. Between November 2001 and December
2002 all patients admitted to the ICU who were ≥18 years old
and stayed 72 hours or longer were potentially eligible. For
patients with multiple ICU admissions, only the first admission
was recorded. The Ethics Committee of Garcia de Orta Hos-
pital approved the study design and informed consent was
waived in view of the lack of need for additional blood sam-
pling.
Data collected included the admission diagnosis, past medical
history, vital signs, systemic inflammatory response syndrome
(SIRS) [4], the Acute Physiology and Chronic Health Evalua-
tion II (APACHE II) score [16] and the Sequential Organ Fail-
ure Assessment (SOFA) score [17]. CRP and WCC were
measured at admission and then daily until discharge or death.
The temperature was evaluated hourly and daily extreme val-
ues were recorded. Patients were evaluated daily for clinical
evidence of infection, and samples for bacteriological cultures
were collected whenever clinical suspicion was present.
A prospective cohort study design was used segregating only
infected patients and noninfected patients. Infected patients
were those with an ICU-acquired infection according to the
Centers for Disease Control definitions [18], those with posi-
tive cultures and those who were not receiving antibiotics for
at least 5 days before infection diagnosis. Noninfected
patients had no bacteriological or clinical signs of infection,
had never received antibiotics and were discharged alive from
the ICU. For purposes of the time-dependent analysis, day 0
was defined as the day of positive cultures in infected patients
and as the day of ICU discharge in noninfected patients.
Blood samples were obtained from an arterial line at admission
and subsequently every morning at 07:00. Measurement of
Figure 1
Patterns of C-reactive protein (CRP) course before infection diagnosis or intensive care unit discharge Patterns of C-reactive protein (CRP) course before infection diagnosis or intensive care unit discharge. Four patterns of CRP course between day -
5 and day 0 before infection diagnosis or intensive care unit discharge of individual patients are displayed according to a previously defined CRP 
cutoff value for infection diagnosis of 8.7 mg/dl [19]. See text for definition of patterns A–D. Dashed line, CRP cutoff value for infection diagnosis.Available online http://ccforum.com/content/10/2/R63
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CRP was made by an immunoturbidimetric method using a
commercially available kit (Tina-quant CRP; Roche Diagnos-
tics, Mannheim, Germany). The precision of the assay calcu-
lated by the intra-assay and inter-assay coefficient of variation
was <7%, the sensitivity of the method was 0.1 mg/dl and the
detection limit was 0.3 mg/dl.
Some additional variables were analyzed: the maximum daily
CRP, temperature and WCC variations (calculated by com-
puting the greatest absolute difference from the previous day's
level) and the ∆CRP (calculated by computing day 0 concen-
trations minus the lowest CRP value).
We defined four patterns of CRP course before infection diag-
nosis or discharge (Figure 1) according to a previously identi-
fied CRP cutoff value for infection diagnosis of 8.7 mg/dl [19].
Pattern A occurred when the day 0 CRP was >8.7 mg/dl and,
in the previous days, was at least once below the cutoff value.
Pattern B occurred when CRP was always >8.7 mg/dl. Pat-
tern C occurred when the day 0 CRP was ≤8.7 mg/dl and, in
the previous days, was at least once above the cutoff value.
Finally, pattern D occurred when CRP was always ≤8.7 mg/dl.
The progression of CRP, temperature, WCC and SOFA score
from day -5 to day 0 was analyzed, comparing infected
patients and noninfected patients. Patients were also retro-
spectively classified according to the individual CRP pattern,
assessing its correlation with the clinical course.
Statistical analysis
Results are expressed as the mean ± standard deviation
unless stated otherwise. To assess differences between the
two main groups the Student's t test and the Mann-Whitney U
test were used for continuous variables and the χ2 test was
used for categorical variables. Time-dependent analysis of dif-
ferent variables was performed with general linear model, uni-
variate, repeated-measures analysis using a split-plot design
approach.
Receiver operating characteristics curves were plotted for the
maximum daily CRP, temperature and WCC variations, and for
∆CRP. The accuracy of these variables was assessed by cal-
culating the area under the curve (AUC). In medical practice,
a diagnostic test with an AUC <0.75 would be regarded as
noncontributive [20].
Table 1
Demographic characteristics of the infected and noninfected patients
General characteristic Noninfected patients (n = 28) Infected patients (n = 35) P
Age (mean ± standard deviation) 50.6 ± 21.9 62.2 ± 13.3 0.05
Sex (male/female) 13/15 24/11 0.08
APACHE II score (mean ± standard deviation) 17.3 ± 9.3 20.5 ± 6.1 0.11
Primary admission intensive care unit diagnosis (n) 0.063
Respiratory 4 11
Cardiovascular 8 7
Neurology 6 3
Surgical 1 5
Trauma 3 7
Obstetrics 4
Others 2 2
Primary sites of infection (n)
Respiratory 20
Blood 11
Gastrointestinal 3
Skin and soft tissues 1
SOFA score, day 0 (mean ± standard deviation) 3.0 ± 1.7 6.3 ± 2.9 <0.001
C-reactive protein, day 0 [median (interquartile range)] 3.0 (4.5) 16.6 (9.1) <0.001
APACHE II, Acute Physiology and Chronic Health Evaluation II score; SOFA, Sequential Organ Failure Assessment.Critical Care    Vol 10 No 2    Póvoa et al.
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We created a multivariable logistic regression model to deter-
mine independently associated risk factors best predicting
infection. The studied variables as infection predictors, specif-
ically the maximum daily CRP, temperature and WCC varia-
tions, and ∆CRP as well as the age, sex, APACHE II score and
admission diagnoses, were considered for the multivariable
logistic regression model if they were statistically significant in
bivariate analyses (P < 0.05) and if they had an odds ratio
≥1.2. Before entering the logistic regression model, multicolin-
earity among risk factors was checked by computing the cor-
relation coefficient (r) between variables taken two by two; r <
0.4 was considered low enough to exclude correlation
between the risk factors. Model calibration and discrimination
were assessed using the Hosmer-Lemeshow goodness-of-fit
test and the c statistic, respectively. Results were reported as
the odds ratio with the 95% confidence interval. Significance
was accepted for P < 0.05. Statistical analyses were per-
formed with the use of SPSS software (version 10.0; SPSS
Inc., Chicago, Illinois, USA).
Results
There were 260 patients admitted to our ICU during the study
period, with 181 (69.6%) staying for 72 hours or longer. Of
these patients, 32 never received antibiotics during the ICU
stay. Twenty-eight (15.5%) out of these 32 patients without
antibiotics were discharged alive from the ICU, making up the
noninfected group. The occurrence of documented ICU-
acquired infections in patients not receiving antibiotics for at
least 5 days was diagnosed in 19.3% (n = 35), constituting
the infected group (Table 1). The remaining 114 patients were
excluded from the final analysis.
The number of days without antibiotics before infection diag-
nosis in infected patients and the length of stay among nonin-
fected patients were 6.7 ± 2.9 days and 5.7 ± 3.5 days,
respectively (P = 0.055). Infection was mostly due to bacteria
(97%), and more than one pathogen was isolated in two
cases.
The median (interquartile range) CRP concentrations in
infected and noninfected patients at day 0 were 16.6 (9.1)
mg/dl and 3 (4.5) mg/dl, respectively (P < 0.001). The temper-
ature in infected patients was also significantly higher than in
the noninfected group (38.1 ± 1.0°C and 37.1 ± 0.6°C,
respectively; P < 0.001). The WCC values were equally ele-
vated in both groups (15 ± 8.6 × 103/mm3 and 11.7 ± 4 ×
103/mm3, respectively; P = 0.496).
Time-dependent analysis of CRP (Figure 2) during the 5 days
before the event of interest showed a steady and significant
increase in infected patients, more than twofold, whereas the
CRP level in noninfected patients remained almost unchanged
(P < 0.001). Over the same period, the temperature increased
significantly in infected patients while it decreased slightly in
noninfected patients (P < 0.001) (Figure 2). The time-depend-
Figure 2
C-reactive protein (CRP), temperature and white cell count (WCC)  progression before infection diagnosis or discharge C-reactive protein (CRP), temperature and white cell count (WCC) 
progression before infection diagnosis or discharge. The time-depend-
ent analysis of CRP, temperature and WCC (mean ± standard devia-
tion) from day -5 to day 0 of infected patients and noninfected patients 
is presented. Both the CRP and temperature course clearly differenti-
ate infected patients from noninfected patients (P < 0.001 and P < 
0.001, respectively). Although the WCC time-dependent analysis was 
significantly different (P = 0.005), its progression was unpredictable 
and erratic both in infected patients as well as in noninfected patients.Available online http://ccforum.com/content/10/2/R63
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ent analysis of WCC showed a significant difference between
infected and noninfected patients (P = 0.005), but this finding
resulted from an unpredictable and erratic progression (Figure
2). As a result, WCC comparisons of infected and noninfected
patients between day -5 and day 0 were not significantly dif-
ferent: from 12.9 ± 6.9 to 15 ± 8.6 × 103/mm3 (P = 0.168)
and from 12.2 ± 3.9 to 11.7 ± 4 × 103/mm3, respectively (P
= 0.779).
We then analyzed the maximum daily CRP, temperature and
WCC variations during the study period. The AUC of the max-
imum daily CRP variation as a predictor of infection was 0.86
(95% confidence interval: 0.752–0.933). An increase in CRP
>4.1 mg/dl was a marker of infection prediction with a sensi-
tivity of 92.1% and a specificity of 71.4% (positive likelihood
ratio 3.22, negative likelihood ratio 0.11). The AUCs of the
maximum daily temperature and WCC variations as a predic-
tor of infection were both <0.75: 0.739 (95% confidence
interval: 0.616–0.839) and 0.668 (95% confidence interval:
0.541–0.779), respectively. Finally, we also plotted the
receiver operating characteristics curve of ∆CRP with an area
of 0.879 (95% confidence interval: 0.775–0.946). ∆CRP >5
mg/dl was a marker of infection prediction with a sensitivity of
81.6% and a specificity of 89.3% (positive likelihood ratio
7.61, negative likelihood ratio 0.21).
Among the eight variables (maximum daily CRP, temperature
and WCC variations, ∆CRP, age, sex, APACHE II and admis-
sion diagnoses) entered as independent variables in the bivar-
iate logistic regression equation, only four (maximum daily
CRP, temperature and WCC variations, and ∆CRP) were
found to be good predictors of infection (P < 0.05 and odds
ratio ≥1.2). A significant colinearity was found between the
maximum daily CRP variation and ∆CRP (r = 0.507). As a
result ∆CRP was not entered in the final model. The multivari-
able logistic regression analysis (Table 2) found that only the
maximum daily CRP variation was an independent predictor of
infection (model n = 63, 35 of which developed infection;
AUC = 0.899, goodness-of-fit = 0.593).
Furthermore, we assessed the discrimination between
infected and noninfected patients according to the cutoff
value for infection diagnosis of CRP (>8.7 mg/dl) and temper-
ature (>38.2°C) published elsewhere [19]. In only one
infected patient were all CRP values below the cutoff value
during the study period, while eight noninfected patients pre-
sented CRP >8.7 mg/dl at least once (P < 0.001). Similarly,
concerning temperature >38.2°C, 28 infected patients and 10
noninfected patients showed such a temperature at least once
(P = 0.002). Among the 35 infected patients, 26 showed both
a maximum daily CRP variation >4.1 mg/dl and a temperature
>38.2°C. These variations took place simultaneously in seven
patients. A temperature above the cutoff value occurred
before the CRP variation in seven patients, whereas in 12
patients the CRP changed first.
In the study period, the combination of a maximum daily CRP
variation >4.1 mg/dl plus a concentration >8.7 mg/dl further
increased the discriminative power for infection diagnosis with
a sensitivity of 92.1% and a specificity of 82.1% (positive like-
lihood ratio 5.2, negative likelihood ratio 0.1).
Patterns of the CRP course before infection diagnosis
Patients were retrospectively divided according to the pattern
of CRP evolution during the 5 days before the event of interest
(Figure 1). Twenty-six patients were classified as pattern A, 10
patients as pattern B, six patients as pattern C and 21 patients
as pattern D. The time-dependent analysis of the different CRP
patterns showed that these patterns of evolution were statisti-
cally different (P < 0.001). Almost all patients with patterns A
and B (92% and 90%, respectively) developed an ICU-
acquired infection. On the contrary, only one patient classified
as pattern C and one patient classified as pattern D became
infected (P < 0.001). No relationship between the source of
infection and the CRP pattern of evolution was found (P =
0.748). Time-dependent analysis of temperature according to
the predefined CRP patterns was also significantly different (P
< 0.001). Together patients with patterns A and B showed an
increase in temperature, although not reaching significance (P
= 0.363), whereas a significant decrease was observed in
those patients with patterns C and D (P = 0.001).
Correlation between clinical course and infection 
diagnosis
Clinical evolution during the study period was monitored with
daily assessment of SIRS and the SOFA score. SIRS was
Table 2
Results of multivariable logistic regression model
Odds ratio 95% confidence interval P
Maximum daily C-reactive protein 
variation
1.508 1.201–1.892 <0.001
Maximum daily temperature 
variation
1.126 0.994–1.275 0.061
Maximum daily white cell count 
variation
1.090 0.857–1.388 0.483
Variations per unit of measurement (1 mg/dl C-reactive protein; 0.1°C temperature; 1 × 103/mm3 white cell count).Critical Care    Vol 10 No 2    Póvoa et al.
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present in 95% of infected patients at day 0 as well as in 82%
of the patients ready to be discharged (P = 0.101). The same
was true in the days before the event of interest.
The SOFA score (Figure 3) was significantly different between
both groups (P < 0.001). In infected patients the SOFA score
remained almost unchanged from day -5 to day 0 (6.0 ± 3.2
and 6.3 ± 2.9, respectively; P = 0.332), whereas in nonin-
fected patients a significant decrease was observed (from 6.1
± 2.8 to 3.0 ± 1.7, P = 0.011).
Finally, time-dependent analysis of the SOFA score of the four
CRP patterns showed that the patterns of evolution were sig-
nificantly different (P = 0.002). SOFA scores at day -5 of
patients with patterns A, B, C and D were 5.9 ± 3.1, 6.8 ± 1.9,
6.0 ± 1.0 and 5.7 ± 3.9, respectively (P = 0.91, with one-way
analysis of variance). Later on, at day 0, the SOFA score
changed to 6.0 ± 3.1, 6.6 ± 2.8, 3.3 ± 1.6 and 3.0 ± 1.9,
respectively (P < 0.001, with one-way analysis of variance).
Discussion
Numerous studies have evaluated the usefulness of different
markers, such as CRP [10,19,21] and procalcitonin [10,22],
both in the diagnosis of and in the identification of patients at
risk of infection. These concepts deserve further clarification.
A marker of infection is not present before infection, it appears
concomitantly and ideally precedes the infection, and it disap-
pears with successful therapy or remains elevated if infection
is refractory to treatment [23]. A risk factor of infection is a sign
that identifies a group of patients at risk of developing an infec-
tion in the future.
The majority of published studies [10,11,21,24] evaluated the
discriminative power for infection diagnosis of a single deter-
mination of a particular marker. These variables are not static,
however, but dynamic, as their concentration depends on the
intensity of the inflammatory stimulus; in particular, bacterial
infection. As a result, the aim of the present study was to eval-
uate whether serial CRP measurements could be useful as an
early predictor of infection.
Both fever and leukocytosis are classic markers of infection.
Body temperature has a poor diagnostic performance for
infection. A substantial proportion of infected patients are not
febrile [25], fever is frequently not caused by an infection [6,7]
and temperature is influenced by several noninfectious factors,
such as antipyretics. In our group of patients, fever (defined as
a body temperature >38.2°C [19]) was associated with infec-
tion in almost three-quarters of the febrile patients.
An increase in the WCC is also typically associated with infec-
tion, although leukopenia can also occur [4,26]. The WCC is
also influenced by several noninfectious factors, such as cor-
ticoids. As a result, several studies found that WCC had a low
diagnostic performance for infection [10,11,19,27]. The same
was true in our series.
Interestingly, several authors found that an infection should be
suspected with a steady CRP increase over 2 or 3 days, in the
absence of any intervention able to mount an inflammatory
response, such as surgery [10,28-30]. To our knowledge,
there is only one study that has looked at the behavior of CRP
before infection diagnosis [31]. In that study, performed with
critically ill patients, a 25% or greater increase in the CRP con-
centration from the previous day's level was highly suggestive
of infection. Additionally, several reports with trauma and sur-
gical patients have demonstrated that a failure of CRP levels
to fall or a secondary rise of CRP levels was highly suggestive
of an infectious complication [28,32-34]. Our results showed
that a maximum daily CRP variation >4.1 mg/dl from the previ-
ous day's level was highly suggestive of an ICU-acquired
infection, and if in addition the absolute CRP concentration
reached 8.7 mg/dl [19], it further increased the predictive
value for infection. In our series, infection developed in 88% of
the patients with both criteria.
The presence of SIRS was never helpful in distinguishing
infected patients from noninfected patients, as other studies
have already pointed out [35,36]. Conversely, we found a sig-
nificant and steady decrease of the SOFA score in nonin-
fected patients while the SOFA score in infected patients
Figure 3
Clinical course evaluated by the Sequential Organ Failure Assessment  (SOFA) score in infected and noninfected patients Clinical course evaluated by the Sequential Organ Failure Assessment 
(SOFA) score in infected and noninfected patients. The SOFA score 
(mean ± standard deviation) between day -5 and day 0 of infected 
patients and noninfected patients is shown. In infected patients the 
SOFA score remained almost unchanged, whereas a significant 
decrease was observed in noninfected patients (P < 0.001).Available online http://ccforum.com/content/10/2/R63
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remained elevated without significant changes. We went fur-
ther in our analysis to assess the relationship between CRP
patterns with the SOFA score. Patients with patterns A and B
showed a persistently elevated organ failure, while the SOFA
score decreased steadily over time in patients with patterns C
and D.
Some limitations to our investigation should be noted. This
was a cohort single-center observational study using variables
that are collected daily and are readily available at the bedside
with the aim of predicting infection. In addition, the study
included only ICU-acquired infections.
Moreover, some strengths of our work should be addressed.
Apart from the study of Matson and colleagues [31], we are
not aware of any other report investigating the usefulness of
serial measurements of a sepsis marker to predict infection in
critically ill patients. In addition, we identified different patterns
of CRP progression, with different clinical courses and corre-
lations with infection. As a result, we speculate that infection
should be strongly suspected in patients with patterns A and
B, and consequently a thorough diagnostic work-up should be
performed. In contrast, infection is considered very unlikely in
patients with patterns C and D, and antibiotic therapy could
eventually be withheld in the absence of a strong clinical sus-
picion of infection.
Conclusion
The data of the present study indicate that daily CRP determi-
nations could be useful as a marker of infection prediction,
since patients presenting a maximum daily CRP variation >4.1
mg/dl plus a CRP level >8.7 mg/dl had an 88% risk of ICU-
acquired infection. In addition, the recognition of the patterns
of CRP progression adds more information about the individ-
ual clinical course. Both the temperature and WCC were not
very useful as markers of infection prediction. Serial CRP
measurements might consequently be of some help in the clin-
ical decision-making process; namely, guiding culture sam-
pling as well as empirical prescription of antibiotics. Further
studies to assess the clinical impact of daily CRP monitoring
should be performed.
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